Hemagglutinometer for monitoring warfarin stable dose after heart valve replacement

By using the design of the expansion and squeezing airbags and touch sensors in the blood condensate, the patient's blood -like pollution and blood removal of blood -sampled blood -sampled blood -like blood caused by squeezing blood after monitoring the stable dosage of Huafarin after the replacement of the heart valve was solved. The rapid and comprehensive dripping detection board was achieved, which improved the detection efficiency.

CN222398390UActive Publication Date: 2025-01-28THE SECOND AFFILIATED HOSPITAL OF GUIZHOU MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202420691866.0
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2024-04-07
Publication Date
2025-01-28
Estimated Expiration
2034-04-07

AI Technical Summary

Technical Problem

After heart valve replacement, when patients use hemoglobin to monitor the stable dose of warfarin, artificial blood squeezing can easily lead to blood sample contamination and delay blood withdrawal time, increase the risk of blood sample failure and affect treatment efficiency.

Method used

Designed a blood condensate based on expansion and squeezing airbags and touch sensors. Blood is used by expanding squeezing blood gas sac to ensure blood quickly and comprehensively dripping into the detection board, reducing the risk of manual intervention, and touching induction through touch induction. Optimize the auxiliary squeezing process.

Benefits of technology

The blood -like pollution and blood removal time caused by artificial squeezing blood are effectively avoided, the blood removal hand pointed out the auxiliary squeezing fastness of the blood, reducing the risk of blood -like failure, and improving the efficiency of the use of the blood condensate.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222398390U_ABST
    Figure CN222398390U_ABST
Patent Text Reader

Abstract

The utility model discloses a coagulometer based on monitoring warfarin stable dose after heart valve replacement, which belongs to the field of coagulometers, and comprises a coagulometer body, a detection notch is arranged on the front side of the upper end of the coagulometer body, and the detection notch is arranged on the front side of the upper end of the coagulometer body. The left end and the right end of the detection notch are fixedly connected with inflation cavities, the inner ends of the inflation cavities are fixedly connected with miniature air bags, the left inner wall and the right inner wall of the detection notch are symmetrically and fixedly connected with expansion blood squeezing air bags, and the ends, close to each other, of the two expansion blood squeezing air bags are fixedly connected with touch sensors. During use, the expansion blood squeezing air bag can be matched with the touch sensor to squeeze the two sides of a blood taking finger, blood can drop out rapidly and comprehensively, the risk that blood samples are polluted and the golden time of blood taking is delayed due to manual blood squeezing is avoided, the auxiliary squeezing rapidness of the bleeding position of the blood taking finger is improved, and the blood taking efficiency is improved. And the risk of blood sample failure is avoided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the field of blood coagulation instruments, and more specifically to a blood coagulation instrument for monitoring the stable dose of warfarin after heart valve replacement. Background Art

[0002] Patients who have undergone mechanical valve replacement surgery need long-term oral anticoagulant treatment, mainly warfarin, and need to adjust the dosage of warfarin based on regular coagulation test results, mainly including the international normalized value (INR) and thrombin time (PT). If the dosage is large, the INR value will increase, resulting in gingival bleeding, subcutaneous bleeding, and even cerebral hemorrhage and gastrointestinal bleeding in severe cases; when the dosage is small, the INR will decrease, and there is a risk of embolism. In severe cases, cerebral infarction, pulmonary embolism, lower limb embolism, etc. may occur. Whether the coagulation results are high or low, it will cause serious complications and even endanger life.

[0003] While patients who have undergone heart valve replacement surgery are mainly treated with warfarin, when using a convenient coagulation analyzer to test the coagulation results, the patients are required to draw blood manually, and the blood sample requires a whole drop of complete blood. Improper operation during manual blood squeezing can easily cause blood sample contamination and delay the golden time for blood drawing. The risk of blood sample failure is greatly increased, which is not conducive to ensuring the treatment efficiency of the coagulation analyzer for patients who are mainly treated with warfarin. Utility Model Content

[0004] 1. Technical issues to be solved

[0005] In view of the problems existing in the prior art, the purpose of the utility model is to provide a coagulation meter for monitoring the stable dose of warfarin after heart valve replacement surgery. When in use, the inflated blood squeezing air bag cooperates with the touch sensor to squeeze the two sides of the blood drawing finger, so as to facilitate the rapid and comprehensive dripping of blood, avoid the risk of blood sample contamination and delay of the golden time for blood drawing caused by artificial blood squeezing, and help to improve the speed of auxiliary squeezing of the bleeding site of the blood drawing finger, avoiding the risk of blood sample failure.

[0006] 2. Technical solution

[0007] To solve the above problems, the utility model adopts the following technical solutions.

[0008] A coagulation meter for monitoring the stable dose of warfarin after heart valve replacement surgery comprises a coagulation meter body, a detection slot is provided on the front side of the upper end of the coagulation meter body, both left and right ends of the detection slot are fixedly connected with inflation chambers, the inner end of the inflation chamber is fixedly connected with a micro airbag, the left and right inner walls of the detection slot are symmetrically fixedly connected with expansion and blood squeezing airbags, the two expansion and blood squeezing airbags are respectively connected with the output ends of the corresponding micro airbags, the ends of the two expansion and blood squeezing airbags that are close to each other are fixedly connected with touch sensors, and the touch sensors are located at the highest protruding point of the expansion and blood squeezing airbags.

[0009] Furthermore, a detection plate is placed on the lower inner wall of the detection slot, and the detection plate is snapped into the body of the coagulation analyzer.

[0010] Furthermore, a blood-collecting finger is placed at the inner end of the detection notch, and the blood-collecting finger is located between the two inflated blood-squeezing air bags.

[0011] Furthermore, the blood sampling finger is located directly above the detection plate, and a rotating shaft is rotatably connected between the left and right inner walls of the detection slot.

[0012] Furthermore, a mirror plate is fixedly connected to the outer end of the rotating shaft, and the mirror plate cooperates with the detection notch.

[0013] Furthermore, a display screen is fixedly connected to the upper end of the coagulation instrument body, and a plurality of power supply interfaces are fixedly connected to the right end of the coagulation instrument body.

[0014] Furthermore, a plurality of bottom suction cups are fixedly connected to the lower end of the coagulation instrument body, and the plurality of bottom suction cups are respectively located at the four corners of the lower end of the coagulation instrument body.

[0015] 3. Beneficial effects

[0016] Compared with the prior art, the advantages of the present invention are:

[0017] (1) When using this scheme, the belly of the blood-drawing finger is punctured with a disposable needle to draw blood. After puncturing, the blood-drawing finger is immediately placed downward in the detection slot of the coagulation analyzer body. At this time, the inflatable blood-squeezing air bags on both sides of the blood-drawing finger are inflated by the micro-air bags in the inflation chamber. The inflated blood-squeezing air bags squeeze the positions on both sides of the blood-drawing finger, so that the blood in the blood-drawing finger can be quickly and comprehensively dripped into the designated position on the detection plate. The detection plate can be measured by the coagulation analyzer body to obtain the test results, avoiding the risk of blood sample contamination caused by artificial blood squeezing and delaying the golden time for blood collection.

[0018] (2) When the two blood-drawing fingers extend between the two inflatable blood-squeezing air bags, the touch sensor arranged between the two inflatable blood-squeezing air bags contacts the blood-drawing fingers. After the touch sensor receives a signal, the connected controller can immediately start the micro air bag to inflate the inflatable blood-squeezing air bag, which is beneficial to improve the speed of auxiliary squeezing of the bleeding part of the blood-drawing fingers and avoid the risk of blood sample failure due to delay for too long.

[0019] (3) At the same time, when the blood-drawing finger is bleeding, a mirror stand with a reflective function is set on the front side of the detection slot. The mirror stand can facilitate the patient to check the bleeding situation at the bleeding site in real time, avoid the problem of insufficient bleeding volume or insufficient blood drop accuracy caused by the skewed bleeding point, and help to ensure the patient's detection efficiency. After use, the mirror stand can be flipped through the shaft and placed horizontally with the lower wall of the detection slot, which is convenient for storing the mirror stand and carrying the entire coagulation analyzer body. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 This is a schematic diagram of the axial structure of the blood coagulation analyzer body of the utility model;

[0021] Figure 2 For the utility model Figure 1 Schematic diagram of the partially cut-off and enlarged structure of the blood coagulation analyzer body;

[0022] Figure 3 This is a schematic diagram of the operation state structure of the blood sampling finger of the utility model;

[0023] Figure 4 It is a schematic diagram of the top cross-sectional structure of the inflation chamber of the utility model.

[0024] Description of the numbers in the figure:

[0025] 1. Coagulation analyzer body; 2. Display screen; 3. Detection slot; 4. Inflation chamber; 5. Inflatable blood squeezing airbag; 6. Rotating shaft; 7. Mirror vertical plate; 8. Detection board; 9. Power interface; 10. Bottom suction cup; 11. Blood collection finger; 12. Micro airbag; 13. Touch sensor. DETAILED DESCRIPTION

[0026] The technical solutions in the embodiments of the utility model will be clearly and completely described below in conjunction with the drawings in the embodiments of the utility model; it is obvious that the described embodiments are only part of the embodiments of the utility model, rather than all of the embodiments, and all other embodiments obtained by ordinary technicians in this field based on the embodiments of the utility model without making creative work are within the scope of protection of the utility model.

[0027] In the description of the present invention, it should be noted that the terms "upper", "lower", "inner", "outer", "top / bottom" and the like indicate positions or positional relationships based on the positions or positional relationships shown in the drawings, and are only for the convenience of describing the present invention and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific position, be constructed and operated in a specific position, and therefore cannot be understood as limiting the present invention. In addition, the terms "first" and "second" are used for descriptive purposes only, and cannot be understood as indicating or implying relative importance.

[0028] In the description of the present utility model, it should be noted that, unless otherwise clearly specified and limited, the terms "installed", "provided with", "set / connected", "connected", etc. should be understood in a broad sense. For example, "connected" can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or it can be indirectly connected through an intermediate medium, or it can be the internal communication of two components. For ordinary technicians in this field, the specific meanings of the above terms in the present utility model can be understood according to specific circumstances.

[0029] Embodiment 1:

[0030] See also Figure 1-2 4. A coagulation meter for monitoring the stable dose of warfarin after heart valve replacement surgery comprises a coagulation meter body 1. A detection slot 3 is provided on the front side of the upper end of the coagulation meter body 1. Both left and right ends of the detection slot 3 are fixedly connected with an inflation chamber 4. The inner end of the inflation chamber 4 is fixedly connected with a micro airbag 12. The left and right inner walls of the detection slot 3 are symmetrically fixedly connected with expansion and blood squeezing airbags 5. The two expansion and blood squeezing airbags 5 are respectively connected with the output ends of the corresponding micro airbags 12. The ends of the two expansion and blood squeezing airbags 5 that are close to each other are fixedly connected with a touch sensor 13. The touch sensor 13 is located at the highest protruding point of the expansion and blood squeezing airbag 5.

[0031] See also Figure 2-4 A blood-drawing finger 11 is placed at the inner end of the detection slot 3, and the blood-drawing finger 11 is located between the two inflated blood-squeezing air bags 5. The blood-drawing finger 11 is located directly above the detection plate 8. A rotating shaft 6 is rotatably connected between the left and right inner walls of the detection slot 3, and a mirror vertical plate 7 is fixedly connected to the outer end of the rotating shaft 6. The mirror vertical plate 7 cooperates with the detection slot 3. At the same time, when the blood-drawing finger 11 bleeds, a mirror vertical plate 7 with a reflection function is arranged on the front side of the detection slot 3. The mirror vertical plate 7 can facilitate the patient to check the bleeding situation at the bleeding site in real time, avoid the problem of insufficient bleeding volume or insufficient blood dripping accuracy caused by the skewed bleeding point, and is beneficial to ensuring the patient's detection efficiency. After use, the mirror vertical plate 7 can be flipped over by the rotating shaft 6 and placed horizontally with the lower wall of the detection slot 3, which is convenient for storing the mirror vertical plate 7 and carrying the blood coagulation instrument body 1 as a whole

[0032] See also Figure 3-4 A detection plate 8 is placed on the lower inner wall of the detection slot 3, and the detection plate 8 is snapped into the coagulation instrument body 1. The upper end of the coagulation instrument body 1 is fixedly connected with a display screen 2, and the right end of the coagulation instrument body 1 is fixedly connected with a plurality of power interfaces 9. The lower end of the coagulation instrument body 1 is fixedly connected with a plurality of bottom suction cups 10, and the plurality of bottom suction cups 10 are respectively located at the four corners of the lower end of the coagulation instrument body 1, and the bottom suction cups 10 are conducive to improving the stability of the coagulation instrument body 1.

[0033] See also Figure 1-4In this scheme, the patient first completes the heart valve surgery, and uses warfarin after the surgery to prevent thrombosis and valve jamming. During the warfarin administration period, the patient's blood needs to be checked at any time using the coagulation analyzer body 1 to ensure the anticoagulant effect of warfarin after the heart valve surgery and assist the patient's recovery. When the patient uses the coagulation analyzer body 1, the abdomen of the blood collection finger 11 is punctured with a disposable needle to collect blood. After puncturing, the blood collection finger 11 is immediately placed in the detection slot 3 in the coagulation analyzer body 1 downward. At this time, the expanded blood squeezing airbags 5 on both sides of the blood collection finger 11 are inflated by the micro airbags 12 in the inflation chamber 4, and the expanded blood squeezing airbags 5 squeeze the positions on both sides of the blood collection finger 11, that is, The blood in the blood-drawing finger 11 can be conveniently dripped into the designated position on the detection plate 8 quickly and comprehensively, and the detection result can be obtained by measuring the detection plate 8 with the coagulometer body 1, thereby avoiding the risk of blood sample contamination and delaying the golden time for blood drawing caused by artificial blood squeezing. When the two blood-drawing fingers 11 extend between the two inflatable blood squeezing air bags 5, the touch sensor 13 arranged between the two inflatable blood squeezing air bags 5 contacts the blood-drawing finger 11. After the touch sensor 13 receives the signal, the connected controller can immediately start the micro air bag 12 to inflate the inflatable blood squeezing air bag 5, which is beneficial to improve the quickness of auxiliary squeezing of the bleeding part of the blood-drawing finger 11 and avoid the risk of blood sample failure caused by delaying too long.

[0034] The above are only preferred specific implementations of the utility model; however, the protection scope of the utility model is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical solution and improved ideas of the utility model within the technical scope disclosed by the utility model, which should be included in the protection scope of the utility model.

Claims

1. A coagulation meter for monitoring the stable dose of warfarin after heart valve replacement, comprising a coagulation meter body (1), characterized in that: A detection slot (3) is provided on the front side of the upper end of the coagulation instrument body (1), and the left and right ends of the detection slot (3) are fixedly connected to an inflation chamber (4), and the inner end of the inflation chamber (4) is fixedly connected to a micro airbag (12). The left and right inner walls of the detection slot (3) are symmetrically fixedly connected to expansion and squeezing airbags (5), and the two expansion and squeezing airbags (5) are respectively connected to the output ends of the corresponding micro airbags (12). The ends of the two expansion and squeezing airbags (5) that are close to each other are fixedly connected to a touch sensor (13), and the touch sensor (13) is located at the highest protruding point of the expansion and squeezing airbag (5).

2. The blood coagulation instrument for monitoring the stable dose of warfarin after heart valve replacement according to claim 1, characterized in that: A detection plate (8) is placed on the lower inner wall of the detection slot (3), and the detection plate (8) is snapped into the blood coagulation instrument body (1).

3. The blood coagulation instrument for monitoring the stable dose of warfarin after heart valve replacement according to claim 1, characterized in that: A blood sampling finger (11) is placed at the inner end of the detection notch (3), and the blood sampling finger (11) is located between two inflated blood squeezing air bags (5).

4. The blood coagulation instrument for monitoring the stable dose of warfarin after heart valve replacement according to claim 3, characterized in that: The blood sampling finger (11) is located directly above the detection plate (8), and a rotating shaft (6) is rotatably connected between the left and right inner walls of the detection slot (3).

5. The blood coagulation instrument for monitoring the stable dose of warfarin after heart valve replacement according to claim 4, characterized in that: The outer end of the rotating shaft (6) is fixedly connected with a mirror vertical plate (7), and the mirror vertical plate (7) and the detection notch (3) cooperate with each other.

6. The blood coagulation instrument for monitoring the stable dose of warfarin after heart valve replacement according to claim 1, characterized in that: The upper end of the coagulometer body (1) is fixedly connected to a display screen (2), and the right end of the coagulometer body (1) is fixedly connected to a plurality of power supply interfaces (9).

7. The blood coagulation instrument for monitoring the stable dose of warfarin after heart valve replacement according to claim 1, characterized in that: A plurality of bottom suction cups (10) are fixedly connected to the lower end of the coagulometer body (1), and the plurality of bottom suction cups (10) are respectively located at the four corners of the lower end of the coagulometer body (1).